Penumbra, Inc. is a medical technology company that develops innovative products to aid patients with stroke and other neurovascular conditions. Its key offerings include the Penumbra System, an ischemic stroke device platform, the Penumbra Coil 400 for aneurysm treatment, the 5MAX ACE clot extraction device, and the Neuron System of access catheters. Headquartered in Alameda, California, Penumbra operates globally, serving regions such as North and South America, Europe, Australia, and Asia.